Spike Protein News and Research

RSS
Phase 2 trial shows INO-4800 SARS-CoV-2 DNA vaccine safe and tolerable in adults

Phase 2 trial shows INO-4800 SARS-CoV-2 DNA vaccine safe and tolerable in adults

SARS-CoV-2 B.1.617 variant shows modest resistance to vaccine-induced antibodies

SARS-CoV-2 B.1.617 variant shows modest resistance to vaccine-induced antibodies

Moderna and Pfizer-BioNTech vaccines induce robust T cell response against SARS-CoV-2 variants

Moderna and Pfizer-BioNTech vaccines induce robust T cell response against SARS-CoV-2 variants

Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages

Enhanced version of CureVac’s COVID-19 vaccine could help address supply shortages

Antibodies generated by malaria cross-react with SARS-CoV-2

Antibodies generated by malaria cross-react with SARS-CoV-2

Immunity developed by SARS-CoV-2 infection can protect against E484K variants, suggests study

Immunity developed by SARS-CoV-2 infection can protect against E484K variants, suggests study

Designer SARS-CoV-2 RBD vaccine produces dramatically improved antibody response in preclinical trials

Designer SARS-CoV-2 RBD vaccine produces dramatically improved antibody response in preclinical trials

Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)

Study reports new monoclonal antibodies with broad neutralizing capabilities against betacoronaviruses (including SARS-CoV-2)

Pfizer-BioNTech COVID-19 vaccine effective in patients with myeloproliferative neoplasms

Pfizer-BioNTech COVID-19 vaccine effective in patients with myeloproliferative neoplasms

Scientists unveil new Ebola virus vaccine design

Scientists unveil new Ebola virus vaccine design

Inexpensive test for rapid detection of COVID-19 with 90% accuracy

Inexpensive test for rapid detection of COVID-19 with 90% accuracy

Spread of minority SARS-CoV-2 variants in New York City

Spread of minority SARS-CoV-2 variants in New York City

Evolutionary-spreading model predicts another devastating COVID-19 peak around July 2021

Evolutionary-spreading model predicts another devastating COVID-19 peak around July 2021

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo

Researchers design compounds that prevent SARS-CoV-2 entry in human lung cells

Researchers design compounds that prevent SARS-CoV-2 entry in human lung cells

MIT researchers generate the complete gene annotation of SARS-CoV-2 genome

MIT researchers generate the complete gene annotation of SARS-CoV-2 genome

The "key" to vaccine development depends on virus’ binding to human cells

The "key" to vaccine development depends on virus’ binding to human cells

The travel-related origin and spread of SARS-CoV-2 B.1.620 strain

The travel-related origin and spread of SARS-CoV-2 B.1.620 strain

Lab reports 1st instance of SARS-CoV-2 variants affecting antigen test performance

Lab reports 1st instance of SARS-CoV-2 variants affecting antigen test performance

New vaccine shows potential to protect from a variety of coronavirus infections

New vaccine shows potential to protect from a variety of coronavirus infections